HemeOncBuddy vs SOHO365
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
HemeOncBuddy
This app provides quick access to practice-changing clinical trials in Hematology and Oncology. It offers simplified summaries of trial background, inclusion/exclusion criteria, primary endpoints, and outcomes for easy reference.
- Practice-changing clinical trial summaries
- Hematology and Oncology focus
- Simplified trial information
- Inclusion and exclusion criteria
- Primary endpoints and outcomes
- Quick reference tool
Read full descriptionHide full description
HemeOncBuddy is a free study hub built for hematology and oncology fellows and trainees - everything you need to keep up with the literature and prep for boards, in one fast, searchable app. WHAT'S INSIDE - 1,500+ pivotal clinical-trial summaries, each in the same structure (background, inclusion criteria, arms, primary/secondary endpoints, median follow-up, key results, notable toxicities) so you can scan them quickly. - A Question Bank with board-style questions, tutor and timed modes, explanations, and progress tracking. - ~2,000 active-recall flashcards across oncology, malignant and benign heme, and pharmacology — plus visual staging decks. - 120+ concise disease-site board-prep notes. - A conference & abstract-deadline tracker so you never miss a submission window. MADE FOR STUDYING - Full dark mode and adjustable text size. - Optional free account (Sign in with Apple, Google, or email) to sync your saved trials, Qbank progress, and notes across iPhone, iPad, and Mac. - No ads. No paywall. No login required to browse. HemeOncBuddy is an educational study aid only. It is not a substitute for medical advice, clinical judgment, or current guidelines, and must not be used to diagnose or treat patients. Always verify against primary literature and current guidelines.
SOHO365
Connect with a global community of hematologic oncology professionals. Access a comprehensive resource center with slides, publications, and videos. Stay updated with the latest news and journal articles, and manage event registrations and reminders.
- Global professional community access
- Comprehensive resource center
- Hematologic oncology discussions
- Access to official journal and news
- Event information and registration
- Customizable reminders and alerts
Read full descriptionHide full description
The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders. Since that time, approximately 8,000 members from 110 countries have joined the society from around the globe. SOHO is a global society designed specifically for clinicians, research scientists and related health care professionals who specialize in the research and treatment of patients with hematologic malignancies. SOHO’s mission is to expedite worldwide research and education through the exchange of scientific information. Organized by its founders and world class committees, SOHO is the only society specific to this field. SOHO represents physicians and other professionals from all corners of the world. SOHO is leading vital efforts to further treatments for those with hematologic malignancies. Become a SOHO Member free-of-charge. Join us and experience the benefits of membership at http://sohoonline.org ! Mobile app features: • Instant connections to our SOHO Community of nearly 8,000 members • Access to a comprehensive Resource Center that includes slides, publications, abstracts, videos and more • Connection to our SOHO DocMatter Community for hematologic oncology discussions, questions and education • Access to our official journal, ‘Clinical Lymphoma Myeloma and Leukemia’and our news publication, 'Blood Cancers Today' • Direct access to event information and registration with significant member-only discounts • Set SOHO reminders and receive alerts within the App • Connect to the App through Facebook, LinkedIn, and Twitter
Screenshots
Verdict
The clearest difference is update cadence: SOHO365 at monthly against HemeOncBuddy's every 24 months. SOHO365 also leads on chart position (#204 vs unranked). HemeOncBuddy's advantage is monetization model (free vs free with in-app purchases) and ratings volume (17 vs 1). On price, rating, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
On the App Store both sit at effectively the same score — 5.0 for HemeOncBuddy against 5.0 for SOHO365. That said, the two scores are not equally well evidenced: HemeOncBuddy has 17 ratings behind it against 1, so its average is the more settled of the two.
HemeOncBuddy ships an update every 24 months, SOHO365 monthly. The most recent releases landed on August 5, 2026 and September 2, 2026 respectively.
| Parameter | HemeOncBuddy | SOHO365 |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (17 ratings) | 5.0 (1 ratings) |
| Positive reviews | 100.0% of reviews | — |
| Number of ratings | 17 — better | 1 |
| Update frequency | Every 24 months | Monthly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free — better | Free with in-app purchases |
| Best chart rank | — | #204 — better |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.0 | 15.0 |
| Further details — not scored | ||
| Size | 16 MB | 58 MB |
| Age rating | 17+ | 17+ |
| Developer | Veli Bakalov | SOCIETY OF HEMATOLOGIC ONCOLOGY |
Customer experience
HemeOncBuddy
SOHO365
In-app purchases
HemeOncBuddy
No in-app purchases
SOHO365
No in-app purchases









